Patents by Inventor George W. Belendiuk

George W. Belendiuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
    Patent number: 5912013
    Abstract: The present invention relates to a composition and method of treating a patient by administering carbamazepine in a pharmaceutical dosage form capable of maintaining the patient's blood concentration at from about 4 .mu.g/ml to about 12 .mu.g/ml over at least a 12 hour period, where the blood concentration of carbamazepine does not vary by more than 60 percent.
    Type: Grant
    Filed: April 21, 1995
    Date of Patent: June 15, 1999
    Assignee: Shire Laboratories, Inc.
    Inventors: Edward M. Rudnic, George W. Belendiuk, John McCarty, Sandra Wassink, Richard A. Couch
  • Emulsified drug delivery system
    Patent number: 5897876
    Abstract: A pharmaceutical preparation comprising a stable, surface-active emulsion or dispersion of a pharmaceutical agent incorporated into an emulsion (i) having a hydrophobic discontinuous phase of a long chain carboxylic acid or ester or alcohol thereof dispersed in an aqueous phase or (ii) having a hydrophilic discontinuous phase dispersed in a hydrophobic phase of a long chain carboxylic acid or alcohol thereof. The emulsion with pharmaceutical agent is incorporated into a pharmaceutical carrier suitable for oral delivery.
    Type: Grant
    Filed: June 20, 1997
    Date of Patent: April 27, 1999
    Assignee: Shire Laboratories Inc.
    Inventors: Edward M. Rudnic, John A. McCarty, George W. Belendiuk, deceased, Beth A. Burnside, Charlotte M. McGuinness, Krystyna Belendiuk
  • Oral acyclovir delivery
    Patent number: 5883103
    Abstract: A pharmaceutical preparation for oral acyclovir delivery comprising a stable, hydrophobic emulsion comprising continuous phase of a hydrophobic material selected from the group consisting of a long chain carboxylic acid or ester or alcohol thereof dispersed in an aqueous phase or (ii) having a hydrophilic discontinuous phase dispersed in a hydrophobic phase of a long chain carboxylic acid or alcohol thereof. The emulsion with acyclovir is incorporated into a pharmaceutical carrier suitable for oral delivery.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 16, 1999
    Assignee: Shire Laboratories Inc.
    Inventors: Beth A. Burnside, Carol E. Mattes, Charlotte M. McGuinness, Edward M. Rudnic, George W. Belendiuk
  • Oral insulin delivery
    Patent number: 5824638
    Abstract: A pharmaceutical preparation for oral insulin delivery comprising a stable, hydrophobic emulsion comprising continuous phase of a hydrophobic material selected from the group consisting of a long chain carboxylic acid or ester or alcohol thereof dispersed in an aqueous phase or (ii) having a hydrophilic discontinuous phase dispersed in a hydrophobic phase of a long chain carboxylic acid or alcohol thereof. The emulsion with insulin is incorporated into a pharmaceutical carrier suitable for oral delivery.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: October 20, 1998
    Assignee: Shire Laboratories, Inc.
    Inventors: Beth A. Burnside, Carol E. Mattes, Charlotte M. McGuinness, Edward M. Rudnic, George W. Belendiuk, deceased
  • Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
    Patent number: 5326570
    Abstract: The present invention relates to a composition and method of treating a patient by administering carbamazepine in a pharmaceutical dosage form capable of maintaining the patient's blood concentration at from about 4 .mu.g/ml to about 12 .mu.g/ml over at least a 12 hour period, where the blood concentration of carbamazepine does not vary by more than 60 percent.
    Type: Grant
    Filed: July 23, 1991
    Date of Patent: July 5, 1994
    Assignee: Pharmavene, Inc.
    Inventors: Edward M. Rudnic, George W. Belendiuk